{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T10:17:13Z","timestamp":1772360233178,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s11030-017-9795-y","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T05:23:09Z","timestamp":1510636989000},"page":"83-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity"],"prefix":"10.1007","volume":"22","author":[{"given":"Kommula","family":"Dileep","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sowjanya","family":"Polepalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudheer Kumar","family":"Buddana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. S.","family":"Prakasham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S. R.","family":"Murty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"9795_CR1","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.bmc.2007.01.030","volume":"15","author":"YL Janin","year":"2007","unstructured":"Janin YL (2007) Antituberculosis drugs: ten years of research. Bioorg Med Chem 15:2479\u20132513. \n                        https:\/\/doi.org\/10.1016\/j.bmc.2007.01.030","journal-title":"Bioorg Med Chem"},{"key":"9795_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S1517-83822014005000033","volume":"45","author":"LC Balsalobre","year":"2014","unstructured":"Balsalobre LC, Dropa M (2014) An overview of antimicrobial resistance and its public health significance. Braz J Microbiol 45:1\u20135. \n                        https:\/\/doi.org\/10.1590\/S1517-83822014005000033","journal-title":"Braz J Microbiol"},{"key":"9795_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1128\/AAC.00665-08","volume":"53","author":"LSK Morgan","year":"2009","unstructured":"Morgan LSK, Becnel BL, Steffen D, Zechiedrich L (2009) Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates. Antimicrob Agents Chemother 53:235\u2013241. \n                        https:\/\/doi.org\/10.1128\/AAC.00665-08","journal-title":"Antimicrob Agents Chemother"},{"key":"9795_CR4","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1016\/j.bmcl.2015.07.071","volume":"25","author":"R Peraman","year":"2015","unstructured":"Peraman R, Varma RV, Reddy YP (2015) Re-engineering nalidixic acid\u2019s chemical scaffold: a step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens. Bioorg Med Chem Lett 25:4314\u20134319. \n                        https:\/\/doi.org\/10.1016\/j.bmcl.2015.07.071","journal-title":"Bioorg Med Chem Lett"},{"key":"9795_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1086\/313954","volume":"31","author":"JG Bartlett","year":"2000","unstructured":"Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 31:347\u2013382. \n                        https:\/\/doi.org\/10.1086\/313954","journal-title":"Clin Infect Dis"},{"key":"9795_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0090-4295(99)00064-3","volume":"54","author":"AM Kamat","year":"1999","unstructured":"Kamat AM, DeHaven JI, Lamm DL (1999) Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer. Urology 54:56\u201361. \n                        https:\/\/doi.org\/10.1016\/S0090-4295(99)00064-3","journal-title":"Urology"},{"key":"9795_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3892\/ijo.22.4.787","volume":"22","author":"O Aranha","year":"2003","unstructured":"Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood DP, Sarkar FH (2003) Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. Int J Oncol 22:787\u2013794. \n                        https:\/\/doi.org\/10.3892\/ijo.22.4.787","journal-title":"Int J Oncol"},{"key":"9795_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/26.suppl_D.1","volume":"26","author":"HW Landuyt","year":"1990","unstructured":"Landuyt HW, Van K, Magerman GB (1990) The importance of the quinolones in antibacterial therapy. J Antimicrob Chemother 26:1\u20136. \n                        https:\/\/doi.org\/10.1093\/jac\/26.suppl_D.1","journal-title":"J Antimicrob Chemother"},{"key":"9795_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3892\/ijo.21.1.207","volume":"21","author":"BF El-Rayes","year":"2002","unstructured":"El-Rayes BF, Grignon R, Aslam N, Aranha O, Sarkar FH (2002) Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells. Int J Oncol 21:207\u2013211. \n                        https:\/\/doi.org\/10.3892\/ijo.21.1.207","journal-title":"Int J Oncol"},{"key":"9795_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0022-5347(01)66516-9","volume":"155","author":"TM Seay","year":"1996","unstructured":"Seay TM, Peretsman SJ, Dixon PSJ (1996) Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. Urol 155:757\u2013762. \n                        https:\/\/doi.org\/10.1016\/S0022-5347(01)66516-9","journal-title":"Urol"},{"key":"9795_CR11","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1002\/(SICI)1097-0142(19971215)80","volume":"80","author":"S Ebisuno","year":"1997","unstructured":"Ebisuno S, Inagaki T, Kohjimoto Y, Ohkawa T (1997) The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro. Cancer 80:2263\u20132267. \n                        https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19971215)80","journal-title":"Cancer"},{"key":"9795_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0304-3835(97)00269-3","volume":"119","author":"M Yamakuchi","year":"1997","unstructured":"Yamakuchi M, Nakata M, Kawahara K, Kitajima I, Maruyama T (1997) New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines. Cancer Lett 119:213\u2013219. \n                        https:\/\/doi.org\/10.1016\/S0304-3835(97)00269-3","journal-title":"Cancer Lett"},{"key":"9795_CR13","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1016\/S0304-3835(97)00269-3","volume":"17","author":"Z Dang","year":"2007","unstructured":"Dang Z, Yang YS, Ji RY, Zhang SH (2007) New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines. Med Chem Lett 17:4523\u20134526. \n                        https:\/\/doi.org\/10.1016\/S0304-3835(97)00269-3","journal-title":"Med Chem Lett"},{"key":"9795_CR14","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1021\/bi00435a039","volume":"28","author":"LL Shen","year":"1989","unstructured":"Shen LL, Mitscher LA, Sharma PN, Odonnell TJ, Chu DWT, Cooper CS, Rosen T, Pernet AG (1989) Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug\u2013DNA binding model. Biochemistry 28:3886\u20133894. \n                        https:\/\/doi.org\/10.1021\/bi00435a039","journal-title":"Biochemistry"},{"key":"9795_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3109\/14756360903373350","volume":"25","author":"PC Sharma","year":"2010","unstructured":"Sharma PC, Jain A, Jain S, Pahwa R, Yar MS (2010) Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects. J Enzyme Inhib Med Chem 25:557\u2013589. \n                        https:\/\/doi.org\/10.3109\/14756360903373350","journal-title":"J Enzyme Inhib Med Chem"},{"key":"9795_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ejmech.2010.11.023","volume":"46","author":"LL Feng","year":"2011","unstructured":"Feng LL, Liu ML, Zhang S, Chai Y, Wang B, Zhang YB, Lv K, Guan Y, Guo HY, Xiao CL (2011) Synthesis and in vitro antimycobacterial activity of 8-OCH(3) ciprofloxacin methylene and ethylene isatin derivatives. Eur J Med Chem 46:341\u2013348. \n                        https:\/\/doi.org\/10.1016\/j.ejmech.2010.11.023","journal-title":"Eur J Med Chem"},{"key":"9795_CR17","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1016\/j.bmcl.2005.07.005","volume":"15","author":"A Foroumadi","year":"2005","unstructured":"Foroumadi A, Emami S, Mehni M, Moshafi MH, Shafiee A (2005) Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2\u20135-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones. Bioorg Med Chem Lett 15:4536\u20134539. \n                        https:\/\/doi.org\/10.1016\/j.bmcl.2005.07.005","journal-title":"Bioorg Med Chem Lett"},{"key":"9795_CR18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/B978-008096518-5.00095-2","volume-title":"Comprehensive heterocyclic chemistry II","author":"RN Butler","year":"1996","unstructured":"Butler RN, Katritzky AR, Rees CW, Scriven EFV (1996) Comprehensive heterocyclic chemistry II. Pergamon Press, Oxford, p 621"},{"key":"9795_CR19","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/S0968-0896(02)00239-0","volume":"10","author":"RJ Herr","year":"2002","unstructured":"Herr RJ (2002) 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods. Bioorg Med Chem 10:3379\u20133393. \n                        https:\/\/doi.org\/10.1016\/S0968-0896(02)00239-0","journal-title":"Bioorg Med Chem"},{"key":"9795_CR20","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.ejmech.2010.01.025","volume":"45","author":"CF Matta","year":"2010","unstructured":"Matta CF, Arabi AA, Weaver DF (2010) The bioisosteric similarity of the tetrazole and carboxylate anions: clues from the topologies of the electrostatic potential and of the electron density. Eur J Med Chem 45:1868\u20131872. \n                        https:\/\/doi.org\/10.1016\/j.ejmech.2010.01.025","journal-title":"Eur J Med Chem"},{"key":"9795_CR21","doi-asserted-by":"publisher","unstructured":"Shemyakina OA, Mal\u2019kina AG, Albanov AI, Trofimov BA (2011) Regio- and stereodirection of addition of tetrazole to \n                        $$\\alpha $$\n                        \n                            \n                                \u03b1\n                            \n                        \n                    ,\n                        $$\\beta $$\n                        \n                            \n                                \u03b2\n                            \n                        \n                    -acetylenic \n                        $$\\gamma $$\n                        \n                            \n                                \u03b3\n                            \n                        \n                    -hydroxy nitrile: synthesis of 1- and 2-(Z)-(2-cyanoethenyl-1-hydroxyalkyl)tetrazoles. Chem Heterocycl Compd 47:464\u2013469. \n                        https:\/\/doi.org\/10.1007\/s10593-011-0782-4","DOI":"10.1007\/s10593-011-0782-4"},{"key":"9795_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1039\/C0MD00263A","volume":"2","author":"CNSSP Kumar","year":"2011","unstructured":"Kumar CNSSP, Parida DK, Santhoshi A, Kota AK, Sridhar B, Rao VJ (2011) Synthesis and biological evaluation of tetrazole containing compounds as possible anticancer agents. Med Chem Commun 2:486\u2013492. \n                        https:\/\/doi.org\/10.1039\/C0MD00263A","journal-title":"Med Chem Commun"},{"key":"9795_CR23","doi-asserted-by":"publisher","DOI":"10.1515\/tjb-2016-0207","author":"Y Leyla","year":"2016","unstructured":"Leyla Y, Zafer AK, Halide ET, G\u00fcl\u015fen A\u00c7 (2016) Novel tetrazole derivatives: synthesis, anticholinesterase activity and cytotoxicity evaluation. Turk J Biochem. \n                        https:\/\/doi.org\/10.1515\/tjb-2016-0207","journal-title":"Turk J Biochem"},{"key":"9795_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00044-016-1514-1","volume":"25","author":"MSR Murty","year":"2016","unstructured":"Murty MSR, Raju P, Polepalli S, Jain N (2016) Synthesis and biological evaluation of novel resveratrol-oxadiazole hybrid heterocycles as potential antiproliferative agents. Med Chem Res 25:627\u2013643. \n                        https:\/\/doi.org\/10.1007\/s00044-016-1514-1","journal-title":"Med Chem Res"},{"key":"9795_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s11030-016-9677-8","volume":"20","author":"MSR Murty","year":"2016","unstructured":"Murty MSR, Katiki MR, Babu NJ, Garimella S, Polepalli S, Jain N, Buddana SK, Prakasham RS (2016) Synthesis and biological evaluation of novel tamoxifen-1,2,4-triazole conjugates. Mol Divers 20:687\u2013703. \n                        https:\/\/doi.org\/10.1007\/s11030-016-9677-8","journal-title":"Mol Divers"},{"key":"9795_CR26","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1007\/s00044-013-0510-y","volume":"22","author":"MSR Murty","year":"2013","unstructured":"Murty MSR, Rao BR, Katiki MR, Nath LR, Anto RJ (2013) Synthesis of piperazinyl benzothiazole\/benzoxazole derivatives coupled with 1,3,4-oxadiazole-2-thiol: novel hybrid heterocycles as anticancer agents. Med Chem Res 22:4980\u20134991. \n                        https:\/\/doi.org\/10.1007\/s00044-013-0510-y","journal-title":"Med Chem Res"},{"key":"9795_CR27","doi-asserted-by":"publisher","first-page":"6751","DOI":"10.1021\/jm200639r","volume":"54","author":"MA Reddy","year":"2011","unstructured":"Reddy MA, Jain N, Yada D, Kishore C, Vangala JR, Surendra PR, Addlagatta A, Kalivendi SV, Sreedhar B (2011) Design and synthesis of resveratrol-based nitrovinylstilbenes as antimitotic agents. J Med Chem 54:6751\u20136760. \n                        https:\/\/doi.org\/10.1021\/jm200639r","journal-title":"J Med Chem"},{"key":"9795_CR28","first-page":"52","volume-title":"Antibiotics in laboratory medicine","author":"D Amsterdam","year":"1996","unstructured":"Amsterdam D (1996) Susceptibility testing of antimicrobials in liquid medium. In: Lorian V, Baltimore MD (eds) Antibiotics in laboratory medicine, 4th edn. Williams & Wilikins, Baltimore, pp 52\u2013111","edition":"4"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-017-9795-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-017-9795-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-017-9795-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T14:31:27Z","timestamp":1519655487000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-017-9795-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["9795"],"URL":"https:\/\/doi.org\/10.1007\/s11030-017-9795-y","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]}}}